[1]
U. Goodman, “ASSESSING THE RISK OF LONG-ACTING OXYTETRACYCLINE ON IMMUNE PARAMETERS IN WISTAR ALBINO RATS”, IJAS, vol. 13, no. 11, pp. 25–29, Nov. 2022.